{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T16:24:22Z","timestamp":1793982262081,"version":"4.8.0"},"reference-count":6,"publisher":"American Society of Hematology","issue":"19","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2018,10,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>New-onset autoimmune hemolytic anemia (AIHA) occurs in 2% to 6% of pediatric patients post\u2013hematopoietic stem cell transplantation (HSCT) and is a significant complication. Incomplete immune recovery following HSCT may predispose to immune dysregulation including autoimmune cytopenias. We describe an innovative therapy for AIHA refractory to proteasome inhibition. In potentially life-threatening AIHA in the context of HSCT, daratumumab may be an effective rescue therapy.<\/jats:p>","DOI":"10.1182\/bloodadvances.2018020883","type":"journal-article","created":{"date-parts":[[2019,10,10]],"date-time":"2019-10-10T03:53:44Z","timestamp":1570679624000},"page":"2550-2553","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":118,"title":["Daratumumab in life-threatening autoimmune hemolytic anemia following hematopoietic stem cell transplantation"],"prefix":"10.1182","volume":"2","author":[{"given":"Catharina","family":"Schuetz","sequence":"first","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9165-1690","authenticated-orcid":false,"given":"Manfred","family":"Hoenig","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Despina","family":"Moshous","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019Immuno-H\u00e9matologie et Rhumatologie P\u00e9diatriques, H\u00f4pital Necker Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"},{"name":"Imagine Institute, Universit\u00e9 Paris Descartes\u2013Sorbonne Paris Cit\u00e9, INSERM UMR 1163, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Christof","family":"Weinstock","sequence":"additional","affiliation":[{"name":"Institute for Transfusion Medicine, Ulm University, Ulm, Germany; and"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Martin","family":"Castelle","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019Immuno-H\u00e9matologie et Rhumatologie P\u00e9diatriques, H\u00f4pital Necker Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Matthieu","family":"Bendavid","sequence":"additional","affiliation":[{"name":"Unit\u00e9 d\u2019Immuno-H\u00e9matologie et Rhumatologie P\u00e9diatriques, H\u00f4pital Necker Enfants Malades, Assistance Publique\u2013H\u00f4pitaux de Paris, Paris, France;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kristin","family":"Shimano","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Blood and Marrow Transplant, Benioff Children\u2019s Hospital, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Vanessa","family":"Tolbert","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Blood and Marrow Transplant, Benioff Children\u2019s Hospital, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ansgar S.","family":"Schulz","sequence":"additional","affiliation":[{"name":"Department of Pediatrics and Adolescent Medicine, University Medical Center Ulm, Ulm, Germany;"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6146-3952","authenticated-orcid":false,"given":"Christopher C.","family":"Dvorak","sequence":"additional","affiliation":[{"name":"Division of Allergy, Immunology and Blood and Marrow Transplant, Benioff Children\u2019s Hospital, University of California, San Francisco, San Francisco, CA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","published-online":{"date-parts":[[2018,10,5]]},"reference":[{"issue":"4","key":"2020021108370132400_B1","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1111\/petr.12455","article-title":"The incidence of autoimmune hemolytic anemia in pediatric hematopoietic stem cell recipients post-first and post-second hematopoietic stem cell transplant","volume":"19","author":"Ahmed","year":"2015","journal-title":"Pediatr Transplant"},{"issue":"2","key":"2020021108370132400_B2","doi-asserted-by":"crossref","first-page":"264","DOI":"10.1016\/j.bbmt.2013.11.011","article-title":"Analysis of donor and recipient ABO incompatibility and antibody-associated complications after allogeneic stem cell transplantation with reduced-intensity conditioning","volume":"20","author":"Watz","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"2","key":"2020021108370132400_B3","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/j.bbmt.2013.11.014","article-title":"Autoimmune hematological diseases after allogeneic hematopoietic stem cell transplantation in children: an Italian multicenter experience","volume":"20","author":"Faraci","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"issue":"1","key":"2020021108370132400_B4","doi-asserted-by":"crossref","first-page":"28","DOI":"10.1177\/2040620716677523","article-title":"An update on the role of daratumumab in the treatment of multiple myeloma","volume":"8","author":"Costello","year":"2017","journal-title":"Ther Adv Hematol"},{"issue":"1","key":"2020021108370132400_B5","doi-asserted-by":"crossref","first-page":"95","DOI":"10.1111\/imr.12389","article-title":"Monoclonal antibodies targeting CD38 in hematological malignancies and beyond","volume":"270","author":"van de Donk","year":"2016","journal-title":"Immunol Rev"},{"issue":"6","key":"2020021108370132400_B6","doi-asserted-by":"crossref","first-page":"697","DOI":"10.1007\/s00262-017-1990-2","article-title":"The multi-faceted potential of CD38 antibody targeting in multiple myeloma","volume":"66","author":"Shallis","year":"2017","journal-title":"Cancer Immunol Immunother"}],"container-title":["Blood Advances"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/19\/2550\/1629347\/advances020883.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/bloodadvances\/article-pdf\/2\/19\/2550\/1629347\/advances020883.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,11]],"date-time":"2020-02-11T09:07:05Z","timestamp":1581412025000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/bloodadvances\/article\/2\/19\/2550\/16058\/Daratumumab-in-lifethreatening-autoimmune"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10,5]]},"references-count":6,"journal-issue":{"issue":"19","published-print":{"date-parts":[[2018,10,9]]}},"URL":"https:\/\/doi.org\/10.1182\/bloodadvances.2018020883","relation":{},"ISSN":["2473-9529","2473-9537"],"issn-type":[{"value":"2473-9529","type":"print"},{"value":"2473-9537","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,10,5]]}}}